Cargando…

Tanshinone IIA alleviates atherosclerosis in LDLR(−/−) mice by regulating efferocytosis of macrophages

Background: Tanshinone IIA (TIIA) is the major lipid-soluble active ingredient of the traditional Chinese medicine Salvia miltiorrhiza, which slows down atherosclerosis (AS). However, it remains unclear whether TIIA has the potential to enhance macrophage efferocytosis and thereby improve atheroscle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiarou, Zhang, Yifan, Feng, Xiaoteng, Du, Min, Li, Sijin, Chang, Xindi, Liu, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598641/ https://www.ncbi.nlm.nih.gov/pubmed/37886125 http://dx.doi.org/10.3389/fphar.2023.1233709

Ejemplares similares

Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR(−/−) Mice and RAW264.7 Cells
por: Zhang, Yifan, et al.
Publicado: (2021)

Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR(−/−) Mice
por: Zhang, Yifan, et al.
Publicado: (2022)

Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy
por: Chang, Xindi, et al.
Publicado: (2023)

Tanshinone IIA: A Review of its Anticancer Effects
por: Fang, Zhong‐ying, et al.
Publicado: (2021)

Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment
por: Zheng, Yanfang, et al.
Publicado: (2022)

Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis
por: Chen, Zhuo, et al.
Publicado: (2014)

Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation
por: Li, SiJin, et al.
Publicado: (2023)

Tanshinone IIA Alleviates the AD Phenotypes in APP and PS1 Transgenic Mice
por: Li, Fengling, et al.
Publicado: (2016)

Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
por: Zhong, Chenhui, et al.
Publicado: (2021)

Salvianolic acid B attenuates the inflammatory response in atherosclerosis by regulating MAPKs/ NF-κB signaling pathways in LDLR-/- mice and RAW264.7 cells
por: Zhang, Yifan, et al.
Publicado: (2022)

The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis
por: Li, SiJin, et al.
Publicado: (2022)

Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation
por: Wen, Jiexia, et al.
Publicado: (2020)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
por: Zhang, Rongjie, et al.
Publicado: (2022)

Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
por: Zhu, Peng-Chong, et al.
Publicado: (2023)

Salvia miltiorrhiza Bunge (Danshen) and Bioactive Compound Tanshinone IIA Alleviates Cisplatin-Induced Acute Kidney Injury Through Regulating PXR/NF-κB Signaling
por: Dou, Jing-Yun, et al.
Publicado: (2022)

Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
por: Xu, Junyao, et al.
Publicado: (2019)

Tanshinone IIA Suppresses Proliferation and Inflammatory Cytokine Production of Synovial Fibroblasts from Rheumatoid Arthritis Patients Induced by TNF-α and Attenuates the Inflammatory Response in AIA Mice
por: Du, Hongyan, et al.
Publicado: (2020)

Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice
por: Babaev, Vladimir R., et al.
Publicado: (2014)

Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
por: Xu, Jin, et al.
Publicado: (2023)

Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)

Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction
por: Mao, Shuai, et al.
Publicado: (2019)

The Cordyceps militaris-Derived Polysaccharide CM1 Alleviates Atherosclerosis in LDLR((-/-)) Mice by Improving Hyperlipidemia
por: Yin, Fan, et al.
Publicado: (2021)

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice
por: Getz, Godfrey S., et al.
Publicado: (2018)

Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
por: Zhai, Xifeng, et al.
Publicado: (2017)

Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis
por: Kumar, Dhananjay, et al.
Publicado: (2023)

Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis
por: Zhou, Zhong-Yan, et al.
Publicado: (2020)

Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis
por: Wang, Lili, et al.
Publicado: (2021)

Antifatigue properties of tanshinone IIA in mice subjected to the forced swimming test
por: Lin, Chueh-Yu, et al.
Publicado: (2017)

Metabolism of Tanshinone IIA, Cryptotanshinone and Tanshinone I from Radix Salvia Miltiorrhiza in Zebrafish
por: Wei, Yingjie, et al.
Publicado: (2012)

Tanshinone IIA Protects Against Cerebral Ischemia Reperfusion Injury by Regulating Microglial Activation and Polarization via NF-κB Pathway
por: Song, Zhibing, et al.
Publicado: (2021)

Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway
por: Qin, Chengdong, et al.
Publicado: (2023)

Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease
por: Feng, Xiaoteng, et al.
Publicado: (2022)

Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL
por: Wang, Baocai, et al.
Publicado: (2017)

Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
por: Song, Qing, et al.
Publicado: (2020)

Tanshinone IIA alleviates cardiac hypertrophy through m6A modification of galectin-3
por: Zhang, Meiqi, et al.
Publicado: (2022)

Catechins: Protective mechanism of antioxidant stress in atherosclerosis
por: Sheng, Yuhan, et al.
Publicado: (2023)

Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
por: Song, Qing, et al.
Publicado: (2022)

Amygdalin Attenuates Atherosclerosis and Plays an Anti-Inflammatory Role in ApoE Knock-Out Mice and Bone Marrow-Derived Macrophages
por: Wang, Yiru, et al.
Publicado: (2020)

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
por: Yurdagul, Arif, et al.
Publicado: (2018)

Tanshinone IIA Sodium Sulfonate Attenuates LPS-Induced Intestinal Injury in Mice
por: Yang, Xin-Jing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vmlt9r7rd34anp0bfskafm3gmb